APA (7th ed.) Citation

A, Z., WA, W., E, A., A, B., PJ, B., SD, B., . . . I, M. (2025). Lanadelumab's impact on hereditary angioedema control and quality of life across disease activity subgroups: Real-world evidence. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 135(5), 560. https://doi.org/10.1016/j.anai.2025.07.025

Chicago Style (17th ed.) Citation

A, Zanichelli, et al. "Lanadelumab's Impact on Hereditary Angioedema Control and Quality of Life Across Disease Activity Subgroups: Real-world Evidence." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology 135, no. 5 (2025): 560. https://doi.org/10.1016/j.anai.2025.07.025.

MLA (9th ed.) Citation

A, Zanichelli, et al. "Lanadelumab's Impact on Hereditary Angioedema Control and Quality of Life Across Disease Activity Subgroups: Real-world Evidence." Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology, vol. 135, no. 5, 2025, p. 560, https://doi.org/10.1016/j.anai.2025.07.025.